The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670251590) is an over-the-wire percutaneous transluminal angioplasty (PTA) balloon designed for peripheral vascular intervention. This 2.5 mm x 150 mm configuration combines a low-profile balloon platform with a paclitaxel drug coating intended to support post-dilatation outcomes in peripheral arteries.
Key Features
- Paclitaxel drug coating with TransPax coating technology for controlled drug transfer to the vessel wall
- Low-dose paclitaxel formulation (2 µg/mm² as specified by the manufacturer for the Ranger DCB platform)
- Balloon dimensions: 2.5 mm diameter x 150 mm length
- Over-the-wire (OTW) catheter design compatible with 0.014" guidewires (verify on current IFU)
- Low crossing profile intended to support navigation through tortuous peripheral anatomy
- Single-use, sterile device packaged for procedural use
Clinical Applications
- Percutaneous transluminal angioplasty of peripheral arteries as defined in the manufacturer's Instructions for Use
- Treatment planning for infrapopliteal or below-the-knee vessels where small-diameter, long-length balloons are indicated per the IFU
- Post-dilatation following peripheral interventions when consistent with labeled use
- Use by trained interventional specialists in catheterization or hybrid suite environments
Product Information
- Brand: Boston Scientific
- Product line: Ranger Drug-Coated PTA Balloon Catheter
- REF/UPN: H74939670251590
- Balloon diameter: 2.5 mm
- Balloon length: 150 mm
- Drug: Paclitaxel with TransPax coating
- Catheter type: Over-the-wire PTA balloon catheter
- Working length: Not specified in the located sources
- Guidewire compatibility: Not specified in the located sources (refer to current IFU)
- Sheath compatibility: Not specified in the located sources (refer to current IFU)
- Sterility: Sterile, single-use
- Category: Peripheral Balloon Catheters